Nature Communications (Jun 2016)

Prosaposin is a regulator of progranulin levels and oligomerization

  • Alexandra M. Nicholson,
  • NiCole A. Finch,
  • Marcio Almeida,
  • Ralph B. Perkerson,
  • Marka van Blitterswijk,
  • Aleksandra Wojtas,
  • Basar Cenik,
  • Sergio Rotondo,
  • Venette Inskeep,
  • Laura Almasy,
  • Thomas Dyer,
  • Juan Peralta,
  • Goo Jun,
  • Andrew R. Wood,
  • Timothy M. Frayling,
  • Christian Fuchsberger,
  • Sharon Fowler,
  • Tanya M. Teslovich,
  • Alisa K. Manning,
  • Satish Kumar,
  • Joanne Curran,
  • Donna Lehman,
  • Goncalo Abecasis,
  • Ravindranath Duggirala,
  • Cyril Pottier,
  • Haaris A. Zahir,
  • Julia E. Crook,
  • Anna Karydas,
  • Laura Mitic,
  • Ying Sun,
  • Dennis W. Dickson,
  • Guojun Bu,
  • Joachim Herz,
  • Gang Yu,
  • Bruce L. Miller,
  • Shawn Ferguson,
  • Ronald C. Petersen,
  • Neill Graff-Radford,
  • John Blangero,
  • Rosa Rademakers

DOI
https://doi.org/10.1038/ncomms11992
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 14

Abstract

Read online

Increasing progranulin (PGRN) levels is a promising approach for treating frontotemporal dementia and other neurodegenerative diseases. Here Nicholson et al.show that the prosaposin (PSAP) locus is associated with plasma PGRN levels and demonstrate that PSAP can alter PGRN levels and its oligomerization.